Press releases
Would you like to join our media distribution list or receive electronic copies of our press releases? Would you like to know more about the HOCHDORF Group? Please contact:
Dr Christoph Hug
Head of Corporate Communications
HOCHDORF Group
Tel. +41 41 914 65 62
Mobile +41 79 859 19 23
christoph.hug@hochdorf.com
Would you like to learn more about us? You are welcome to read our customer magazine "HOCHDORF Inside".
- 30.06.2020Jürg Oleas is elected as Chair of the Board of Directors
- 25.06.2020Geza Somogyi appointed COO of the HOCHDORF Group
- 15.06.2020Answers to the shareholder questions to the AGM on Agenda Item 8
- 05.06.2020Information about the Annual General Meeting on 30 June 2020
- 25.05.2020Nanette Haubensak appointed CFO of the HOCHDORF Group
- 06.05.2020HOCHDORF Group continues to sharpen its focus
- 19.03.20202019: A challenging year of transformation
- 26.02.2020HOCHDORF to part from German milk plant
- 17.02.2020Board of Directors of HOCHDORF must be recomposed
- 16.01.2020Our response to questions raised by Stichting General Holdings
- 19.12.2019Dr Peter Pfeilschifter appointed CEO of the HOCHDORF Group
- 19.12.2019HOCHDORF Group receives motion to convene Extraordinary General Meeting
- 13.12.2019Closing of the sale of the Pharmalys stake to Pharmalys Invest Holding
- 08.12.2019HOCHDORF sells Pharmalys stake to Pharmalys Invest Holding
- 14.11.2019Jürgen Brandt appointed new CFO of the HOCHDORF Group
- 04.11.2019Amir Mechria converts part of Mandatory Convertible Bond
- 23.10.2019HOCHDORF Group extends syndicated loan and agrees an additional CHF 30 million credit facility
- 01.10.2019Frank Hoogland to leave the HOCHDORF Group at the end of March 2020
- 26.08.2019Dr Peter Pfeilschifter assumes role of CEO at Pharmalys Laboratories SA
- 21.08.2019Amir Mechria resigns from the Board of Directors of Pharmalys Laboratories SA
- 20.08.2019HOCHDORF must realign itself
- 07.08.2019Sale of HOCHDORF South Africa Ltd
- 08.07.2019HOCHDORF realigns its business
- 13.05.2019Integration of subsidiaries bigger challenge than expected – strategy update announced
- 12.04.2019Shareholders focus on fresh impetus – HOCHDORF receives four new board members
- 19.03.2019Implementation of strategy continues – expected earnings not yet realised
- 13.03.2019Nominations for the Board of Directors
- 11.03.2019Dr Thomas Eisenring resigns as CEO
- 10.12.2018Sales delays and inventory write-downs impact net income
- 21.11.2018Milk from Eastern Switzerland for HOCHDORF infant formula
- 30.08.2018HOCHDORF expecting a significant improvement in the second half of the year
- 18.07.2018Michel Burla to leave the HOCHDORF Group at the end of this year
- 19.06.2018HOCHDORF parts company with milk plant in Lithuania
- 24.05.2018HOCHDORF takes over traditional Swiss brand Bimbosan
- 07.05.2018Dividend increase thanks to good result
- 05.04.2018HOCHDORF: Successful forward integration
- 05.04.2018HOCHDORF: erfolgreiche Vorwärtsintegration (Kopie 2)
- 29.03.2018Werner Schweizer is succeeded by Dr Peter Pfeilschifter
- 31.01.2018Dr Karl Gschwend to retire
- 21.11.2017HOCHDORF successfully places public hybrid bond (SIX/
- 14.11.2017HOCHDORF presents a new quality standard for oils
- 01.11.2017HOCHDORF strengthens its position in Cereals & Ingredients
- 17.08.2017Higher earnings thanks to Pharmalys’ participation
- 04.07.2017Uckermärker Milch to reposition itself on the market
- 08.05.2017Dr Daniel Suter takes on the role of Chairman
- 28.03.2017Closing of the Offering
- 13.03.2017Launch of the mandatory convertible securities
- 13.03.2017HOCHDORF posts record earnings in 2016
- 26.01.2017Sales maintained at last year’s level despite low milk price
- 22.12.2016Frank Hoogland to be Managing Director of Baby Care
- 20.12.2016Closing of the majority shareholding for Pharmalys
- 30.11.2016HOCHDORF moving towards the end user
- 04.11.2016Details of the request for conditional capital increase
- 25.10.2016HOCHDORF signs agreement on majority holding of Pharmalys Laboratories SA
- 17.08.2016Higher revenue despite slightly lower turnover
- 25.07.2016Forward integration with Pharmalys Laboratories SA under examination
- 09.05.2016HOCHDORF drives growth strategy forward
- 07.04.2016HOCHDORF generates solid results
- 27.01.2016HOCHDORF breaks the 500 million Swiss franc barrier
- 26.11.2015HOCHDORF Group press release on early repayment of convertible bond
- 19.08.2015Good operational results generated
- 13.08.2015Frank Hoogland to become Head of Global Marketing & Sales
- 11.05.2015Dividend increase to CHF 3.70 confirmed
- 01.05.2015Christoph Peternell named COO of the HOCHDORF Group
- 26.03.2015Successful and groundbreaking year
- 18.03.2015Fons W. Togtema: New member of the management team
- 29.01.2015Close to 100,000 tonnes of product sold
- 07.01.2015Michiel de Ruiter to leave the HOCHDORF Group
- 06.01.2015A new name in the HOCHDORF Group: HOCHDORF Swiss Nutrition Ltd
- 26.11.2014HOCHDORF takes over German wheat germ processor
- 03.11.2014HOCHDORF Holding Ltd. successfully placed 131'529 new shares. The subscription/placement price was fixed at CHF 135 per share.
- 03.11.2014Capital increase of HOCHDORF Holding Ltd: execution of subscription rights by existing shareholders
- 20.10.2014HOCHDORF Holding Ltd. executes an authorised capital increase in which subscription rights will be granted to existing shareholders
- 22.09.2014HOCHDORF Group takes over Uckermärker Milch GmbH
- 20.08.2014Pleasing results with high capacity usage
- 09.05.2014Dividend increase to CHF 3.20 confirmed
- 08.04.2014A pleasing year thanks to increased efficiency
- 12.03.2014Nominations for the HOCHDORF Group Board of Directors
- 30.01.2014Developments in Sales and Turnover in 2013
- 22.11.2013HOCHDORF organises itself into business areas
- 11.09.2013The HOCHDORF Group is changing
- 06.09.2013HOCHDORF products to conquer Italy
- 21.08.2013A pleasing result under challenging circumstances
- 17.05.2013Generalversammlung stärkt der Führung den Rücken
- 17.04.2013Revaluation leads to positive starting point
- 15.04.2013Dr. Thomas Eisenring to be the new CEO of the HOCHDORF Group
- 23.02.2013Unchanged dividends – new valuation of fixed assets
- 29.01.2013Stable turnover with a greatly reduced milk quantity
- 18.12.2012CEO Damian Henzi leaves HOCHDORF Group
- 04.12.2012Sustainable growth for the HOCHDORF Group in the Chinese market
- 07.11.2012HOCHDORF Group has Latin America in its sights
- 25.10.2012Michel Burla wird neuer Geschäftsführer
- 09.10.2012The HOCHDORF Group wins major new orders from China
- 31.08.2012Dr. Vincent Lebet, Geschäftsführer der HOCHDORF Nutrifood AG, verlässt die HOCHDORF-Gruppe
- 28.08.2012Solides Ergebnis in schwierigem Umfeld
- 11.05.2012Geschärfte Strategie in Umsetzung
- 11.04.2012Ambivalent financial results for 2011
- 31.01.2012Turnover maintained despite sale of division
- 18.08.2011Increased turnover and profits
- 24.06.2011Mousse au Chocolat noir and VIOGERM® wheat germ oil win accolades